| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Molecular Physiology & Biophysics (C.A.A., R.H.), Institute of Hyperexcitability, Jefferson Medical College, Philadelphia, Pa; and Division of Chemistry and Chemical Engineering (A.L.E., D.A.D.), California Institute of Technology, Pasadena.
Correspondence to Dr Christopher Ahern, Departments of Anesthesiology, Pharmacology and Therapuetics, and Cellular and Physiological Sciences, University of British Columbia, 2176 Health Sciences Mall, Vancouver, British Columbia, Canada V6T IZ3. E-mail Christopher.Ahern{at}UBC.ca
Antiarrhythmics, anticonvulsants, and local anesthetics target voltage-gated sodium channels, decreasing excitability of nerve and muscle cells. Channel inhibition by members of this family of cationic, hydrophobic drugs relies on the presence of highly conserved aromatic residues in the pore-lining S6 segment of the fourth homologous domain of the channel. We tested whether channel inhibition was facilitated by an electrostatic attraction between lidocaine and
electrons of the aromatic rings of these residues, namely a cation-
interaction. To this end, we used the in vivo nonsense suppression method to incorporate a series of unnatural phenylalanine derivatives designed to systematically reduce the negative electrostatic potential on the face of the aromatic ring. In contrast to standard point mutations at the same sites, these subtly altered amino acids preserve the wild-type voltage dependence of channel activation and inactivation. Although these phenylalanine derivatives have no effect on low-affinity tonic inhibition by lidocaine or its permanently charged derivative QX-314 at any of the substituted sites, high-affinity use-dependent inhibition displays substantial cation-
energetics for 1 residue only: Phe1579 in rNaV1.4. Replacement of the aromatic ring of Phe1579 by cyclohexane, for example, strongly reduces use-dependent inhibition and speeds recovery of lidocaine-engaged channels. Channel block by the neutral local anesthetic benzocaine is unaffected by the distribution of
electrons at Phe1579, indicating that our aromatic manipulations expose electrostatic contributions to channel inhibition. These results fine tune our understanding of local anesthetic inhibition of voltage-gated sodium channels and will help the design of safer and more salutary therapeutic agents.
Key Words: voltage-gated sodium channels unnatural amino acids local anesthetics cardiac arrhythmias
This article has been cited by other articles:
![]() |
T. Yamagishi, W. Xiong, A. Kondratiev, P. Velez, A. Mendez-Fitzwilliam, J. R. Balser, E. Marban, and G. F. Tomaselli Novel Molecular Determinants in the Pore Region of Sodium Channels Regulate Local Anesthetic Binding Mol. Pharmacol., October 1, 2009; 76(4): 861 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Nayak, S. Harinath, S. Nama, K. Somasundaram, and S. K. Sikdar Inhibition of Human Two-Pore Domain K+ Channel TREK1 by Local Anesthetic Lidocaine: Negative Cooperativity and Half-of-Sites Saturation Kinetics Mol. Pharmacol., October 1, 2009; 76(4): 903 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hanck, E. Nikitina, M. M. McNulty, H. A. Fozzard, G. M. Lipkind, and M. F. Sheets Using Lidocaine and Benzocaine to Link Sodium Channel Molecular Conformations to State-Dependent Antiarrhythmic Drug Affinity Circ. Res., August 28, 2009; 105(5): 492 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Browne, F. E. Blaney, S. P. Yusaf, J. J. Clare, and D. Wray Structural Determinants of Drugs Acting on the Nav1.8 Channel J. Biol. Chem., April 17, 2009; 284(16): 10523 - 10536. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Muroi and B. Chanda Local Anesthetics Disrupt Energetic Coupling between the Voltage-sensing Segments of a Sodium Channel J. Gen. Physiol., December 29, 2008; 133(1): 1 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bruhova, D. B. Tikhonov, and B. S. Zhorov Access and Binding of Local Anesthetics in the Closed Sodium Channel Mol. Pharmacol., October 1, 2008; 74(4): 1033 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Fozzard Increased Sensitivity to Local Anesthetic Drugs: Bedside to Bench Circ. Res., August 15, 2008; 103(4): 325 - 327. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |